Dr. Vinay Prasad's Views on Key ASCO Breast Cancer Trials
Dr. Vinay Prasad is now Director of FDA's CBER Division, Review his thoughts on NATALEE, DESTINY-Breast04, and postMONARCH breast cancer clinical trials
DESTINY-Breast09 is Trending, What About PATINA?
Breast Cancer experts from the global KOL community have been buzzing about DESTINY-Breast09 and PATINA clinical trials. Track their social media insights.